A Case Report of Childhood Polyarteritis Nodosa: A Rare Vasculitic Disorder with Multisystem Involvement

Main Article Content

Fatima Ishaq Abubakar
Baba Jibrin
Maryam Amadou Sanni https://orcid.org/0000-0002-1258-722X
Abubakar Jangebe  Mikailu https://orcid.org/0000-0002-1330-0593
Adetunji Adeniyi Semiyu
Olisa Ochiagha
Aishatu-Yasmin Atusu Alethea

Keywords

Polyarteritis nodosa, childhood, vasculitis, prednisolone, case report

Abstract

Background:Childhood polyarteritis nodosa (cPAN) is a rare systemic necrotizing vasculitis affecting small- and medium-sized arteries. Its heterogeneous clinical manifestations often delay diagnosis, yet early recognition is essential to prevent organ damage. According to the EULAR/PRINTO/PRES criteria, diagnosis requires evidence of necrotizing vasculitis in medium- or small-sized arteries or characteristic clinical features such as skin involvement, myalgia, hypertension, or peripheral neuropathy. This case adds to the limited literature by presenting a severe multisystem form of cPAN in a young child who achieved favorable outcomes with timely corticosteroid therapy.


Case Presentation:A 3-year-old girl presented with a 6-month history of recurrent fever, painful subcutaneous nodules, pruritic rashes, digital gangrene, myalgia, arthralgia, proteinuria, hematuria, and hypertension. Histopathologic examination of skin and subcutaneous nodules demonstrated necrotizing vasculitis of medium-sized arteries, fulfilling the EULAR/PRINTO/PRES classification criteria for cPAN. Treatment with oral prednisolone (1 mg/kg/day) and supportive care led to rapid improvement, including regression of skin lesions, normalization of inflammatory markers, resolution of renal involvement, and sustained remission during follow-up.


Conclusion:This case highlights the need for high clinical suspicion of cPAN in children presenting with multisystem symptoms and characteristic cutaneous findings. Early diagnosis supported by established criteria and prompt corticosteroid therapy, combined with multidisciplinary care, can significantly improve outcomes and reduce long-term morbidity.

Abstract 2 | PDF Downloads 0 EPUB Downloads 0

References

Stanton M, Tiwari V. Polyarteritis Nodosa. [Updated 2023 Feb 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: [https://www.ncbi.nlm.nih.gov/books/NBK557524/](https://www.ncbi.nlm.nih.gov/books/NBK557524/)

Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Duhaut P, et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore). 2005;84(5):313-22. doi:10.1097/01.md.0000180792.80212.5e

Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a retrospective study. Arthritis Rheum. 2010;62(2):616-26. doi:10.1002/art.27299

Sivaraman V, Fisher C, Paxton S. Vasculitis syndromes. In: Kliegman RM, editor. Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier; 2020. p. 5416-20.

Eleftheriou D, Dillon MJ, Tullus K, Marks SD, Pilkington C, Roebuck DJ, et al. Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum. 2013;65(9):2476-85. doi:10.1002/art.38024

Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES classification criteria for childhood polyarteritis nodosa: final validation. Ann Rheum Dis. 2010;69(5):798-806. doi:10.1136/ard.2009.110519

Shivappa SK, Hlawndo JL, Rudramurthy P, Raghuram J, Rao AP. Clinicopathological and morbidity profile of childhood polyarteritis nodosa in a tertiary referral center. Int J Contemp Pediatr. 2020;7(3):696-703. doi:10.18203/2349-3291.ijcp20200702

Kamath P, Verma B, Sawant T. A rare case of childhood polyarteritis nodosa successfully treated with etanercept. Int J Res Med Sci. 2019;7(7):2837-41. doi:10.18203/2320-6012.ijrms20192930

Mondal R, Sarkar S, Pal P, Nandi M, Hazra A, Sabui TK. Childhood polyarteritis nodosa: a prospective multicentre study from eastern India. Indian J Pediatr. 2014;81(4):371-4. doi:10.1007/s12098-013-1256-8

Erden A, Batu ED, Sönmez HE, Arici ZS, Bilginer Y, Ozen S. Comparing polyarteritis nodosa in children and adults: a single center study. Int J Rheum Dis. 2017;20(8):1016-22. doi:10.1111/1756-185X.13120

Alba MA, Flores-Suárez LF, Henderson AG, Xiao H, Hu P, Nachman PH, et al. Interventions for the treatment of polyarteritis nodosa. Cochrane Database Syst Rev. 2019;1(1):CD012913. doi:10.1002/14651858.CD012913.pub2

Cuceoglu MK, Sener S, Batu ED, Bilginer Y, Ozen S. Systematic review of childhood PAN and DADA2. Semin Arthritis Rheum. 2021;51(3):559-64. doi:10.1016/j.semarthrit.2021.04.004

Do N, Ringold S, Brandling-Bennett H. Pediatric cutaneous polyarteritis nodosa treated with TNF-α inhibitor. Pediatr Dermatol. 2019;36(6):932-5. doi:10.1111/pde.13986